1H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis

Experimental and Therapeutic Medicine

Volumn 4, Issue 1, 2012, Pages 165-171

  Wang, Zhigang ^a   Chen, Zhe ^b   Yang, Sisi ^b   Wang, Yu ^b   Yu, Lifang ^a   Zhang, Bicheng ^a   Rao, Zhiguo ^a   Gao, Jianfei ^a   Tu, Shenghao ^b  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Metabolomics; Methotrexate; Nuclear magnetic resonance; Rheumatoid arthritis

Indexed keywords

2 OXOGLUTARIC ACID; ACETIC ACID; ALANINE; ASPARTIC ACID; CHOLESTEROL; CITRIC ACID; CREATININE; CYSTEINE; GLUTAMINE; GLYCINE; HISTIDINE; HYPOXANTHINE; LACTIC ACID; METHIONINE; METHOTREXATE; SERINE; TAURINE; TRIMETHYLAMINE OXIDE; TRYPTOPHAN; URACIL; URIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; DRUG EFFICACY; FEMALE; HUMAN; MALE; METABOLITE; METABOLOMICS; MONOTHERAPY; PARTIAL LEAST SQUARES REGRESSION; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE;

EID: 84865789779     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.567     Document Type: Article

References (30)

1. Scott DL, Wolfe F and Huizinga TW: Rheumatoid arthritis. Lancet 376: 1094-1108, 2010.
2. Rath T and Rubbert A: Drug combinations with methotrexate to treat rheumatoid arthritis. Clin Exp Rheumatol 28: S52-S57, 2010.
3. Saag KG, Teng GG, Patkar NM, et al: American College of Rheumatology 2008 recommendations for the use of non-biologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59: 762-784, 2008.
4. Braun J: Optimal administration and dosage of methotrexate. Clin Exp Rheumatol 28: 46-51, 2010.
5. Ranganathan P and McLeod HL: Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis. Arthritis Rheum 54: 1366-1377, 2006.
6. Dervieux T, Furst D, Lein DO, Capps R, Smith K, Walsh M and Kremer J: Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Arthritis Rheum 50: 2766-2774, 2004.
7. Kawabata T, Nishida K, Takasugi K, et al: Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis. Arthritis Res Ther 12: R133-R145, 2010.
8. Roybal JL, Endo M, Radu A, Zoltick PW and Flake AW: Early gestational gene transfer of IL-10 by systemic administration of lentiviral vector can prevent arthritis in a murine model. Gene Ther 18: 719-726, 2011.
9. Drouin J and Haraoui B; 3e Initiative Group: Predictors of clinical response and radiographic progression in patients with rheumatoid arthritis treated with methotrexate monotherapy. J Rheumatol 37: 1405-1410, 2010.
10. Rudwaleit M, Yin Z, Siegert S, Grolms M, Radbruch A, Braun J and Sieper J: Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor alpha, increase of interleukin 10, and predicted by the initial concentration of interleukin 4. Ann Rheum Dis 59: 311-314, 2000.
11. Nicholson JK and Lindon JC: Systems biology: metabolomics. Nature 455: 1054-1056, 2008.
12. Malet-Martino M and Holzgrabe U: NMR techniques in biomedical and pharmaceutical analysis. J Pharm Biomed Anal 55: 1-15, 2011.
13. Inoue S, Hashiguchi M, Takagi K, Kawai S and Mochizuki M: Preliminary study to identify the predictive factors for the response to methotrexate therapy in patients with rheumatoid arthritis. Yakugaku Zasshi 129: 843-849, 2009.
14. 1H NMR-based metabolomics in rats. Anal Chem 81: 4734-4741, 2009.
15. 1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. Proteome Res 9: 4545-4553, 2010.
16. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324, 1988.
17. Fransen J, Creemers MC and van Riel PL: Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology 43: 1252-1255, 2004.
18. 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. Leukemia 24: 788-797, 2010.
19. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC and Nicholson JK: Metabolic profiling, metabolomic and metabolomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2: 2692-2703, 2007.
20. Okada T, Afendi FM, Altaf-Ul-Amin M, Takahashi H, Nakamura K and Kanaya S: Metabolomics of medicinal plants: the importance of multivariate analysis of analytical chemistry data. Curr Comput Aided Drug Des 6: 179-196, 2010.
21. Bourré-Tessier J and Haraoui B: Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review. J Rheumatol 37: 1416-1421, 2010.
22. Bathon JM, Martin RW, Fleischmann RM, et al: A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343: 1586-1593, 2000.
23. Simoni RE, Gomes LN, Scalco FB, Oliveira CP, Aquino Neto FR and de Oliveira ML: Uric acid changes in urine and plasma: an effective tool in screening for purine inborn errors of metabolism and other pathological conditions. J Inherit Metab Dis 30: 295-309, 2007.
24. 1H NMR spectroscopy. J Proteome Res 6: 3456-3464, 2007.
25. Rees WD, Wilson FA and Maloney CA: Sulfur amino acid metabolism in pregnancy: the impact of methionine in the maternal diet. J Nutr 136: S1701-S1705, 2006.
26. Jámbor A and Molnár-Perl I: Amino acid analysis by high-performance liquid chromatography after derivatization with 9-fluorenylmethyloxycarbonyl chloride. Literature overview and further study. J Chromatogr A 1216: 3064-3077, 2009.
27. Carr DF, Whiteley G, Alfirevic A and Pirmohamed M; FolATED study team: Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review. Pharmacogenomics J 9: 291-305, 2009.
28. Schirra HJ, Anderson CG, Wilson WJ, Kerr L, Craik DJ, Waters MJ and Lichanska AM: Altered metabolism of growth hormone receptor mutant mice: a combined NMR metabolomics and microarray study. PLoS One 3: e2764, 2008.
29. Sadykov MR, Zhang B, Halouska S, et al: Using NMR metabolomics to investigate tricarboxylic acid cycle-dependent signal transduction in Staphylococcus epidermidis. J Biol Chem 285: 36616-36624, 2010.
30. 1H NMR-based metabolomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal 33: 1103-1115, 2003.